You are here

hypertension

IPO Doors Creak Open as Mineralys Seeks $192M

BioSpace

Fri, 02/10/23 - 10:31 am

Mineralys Therapeutics

Mineralys polishes $100M IPO plans ahead of phase 3 in hypertension

Fierce Biotech

Thu, 01/19/23 - 09:59 am

Novartis to pay $245 mln to end antitrust cases over Exforge drug generics

Reuters

Thu, 01/5/23 - 09:57 am

CinCor shares dive after blood pressure drug fails key trial

BioPharma Dive

Mon, 11/28/22 - 07:36 pm

clinical trials

Months removed from a $118M Series B, Mineralys pushes ahead with PhII hypertension data

Endpoints

Thu, 11/17/22 - 11:52 am

J&J, Idorsia plan filings for aprocitentan data in resistant hypertension

Pharmaphorum

Tue, 11/8/22 - 10:33 pm

resistant hypertension

Orchestra BioMed stays on key in extended study of blood pressure reducing device

Fierce Biotech

Wed, 09/21/22 - 10:31 am

Orchestra BioMed

Drugmakers leap back into fading heart drug market

Beckers Hospital Review

Thu, 07/28/22 - 06:40 pm

Bristol Myers Squibb

Alnylam Pharmaceuticals

SoniVie receives FDA approval for Pilot study to treat Hypertension with Renal Artery Denervation TIVUS technology

Drugs.com

Mon, 06/20/22 - 10:47 am

J&J's $230M blood pressure bet hits phase 3 endpoint, but questions linger about blockbuster potential

Fierce Biotech

Mon, 05/23/22 - 10:19 am

clinical trials

Pfizer's blood pressure med recall creeps into US as testing flags carcinogen threat

Fierce Pharma

Mon, 04/25/22 - 10:23 am

product recalls

Medtronic posts positive 3-year data in renal denervation ahead of key pivotal readout

Medtech Dive

Tue, 04/5/22 - 11:51 am

renal denervation

Symplicity Spyral

clinical trials

Pfizer pulls blood pressure medicines in US over cancer-causing impurities

Fierce Pharma

Tue, 03/22/22 - 11:21 pm

product recalls

Medtronic misses bid for early FDA OK in renal denervation, stock slides

Medtech Dive

Mon, 10/18/21 - 11:05 am

renal denervation

clinical trials

CinCor Raises $143 Million To Fund Innovation in Hypertension Research

BioSpace

Wed, 10/13/21 - 10:36 pm

chronic kidney disease

Quiet CinCor Pharma makes some noise with $143M, new trial plans for blood pressure drug

Endpoints

Tue, 10/12/21 - 11:10 am

clinical trials

Sanofi, eyeing impurity concerns, pulls hypertension meds in Korea and the UK. Could the next big 'sartan' recall be on the horizon?

Fierce Pharma

Tue, 08/10/21 - 10:39 am

The future of renal denervation

EP Vantage

Wed, 05/26/21 - 11:27 am

renal denervation

Mineralys emerges with a new take on an old idea for the treatment of hypertension and $40M to play with

Endpoints

Tue, 04/6/21 - 10:16 am

AZ picks up $350m after selling hypertension drugs

Pharmaforum

Mon, 03/2/20 - 09:35 am

Pages